116 related articles for article (PubMed ID: 11589911)
1. Pathophysiological aspects of frontotemporal dementia--emphasis on cytoskeleton proteins and autoimmunity.
Sjögren M; Wallin A
Mech Ageing Dev; 2001 Nov; 122(16):1923-35. PubMed ID: 11589911
[TBL] [Abstract][Full Text] [Related]
2. Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD.
Sjögren M; Rosengren L; Minthon L; Davidsson P; Blennow K; Wallin A
Neurology; 2000 May; 54(10):1960-4. PubMed ID: 10822437
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia.
Landqvist Waldö M; Frizell Santillo A; Passant U; Zetterberg H; Rosengren L; Nilsson C; Englund E
BMC Neurol; 2013 May; 13():54. PubMed ID: 23718879
[TBL] [Abstract][Full Text] [Related]
4. CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls.
Pijnenburg YA; Janssen JC; Schoonenboom NS; Petzold A; Mulder C; Stigbrand T; Norgren N; Heijst H; Hack CE; Scheltens P; Teunissen CE
Dement Geriatr Cogn Disord; 2007; 23(4):225-30. PubMed ID: 17290105
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.
Meeter LHH; Vijverberg EG; Del Campo M; Rozemuller AJM; Donker Kaat L; de Jong FJ; van der Flier WM; Teunissen CE; van Swieten JC; Pijnenburg YAL
Neurology; 2018 Apr; 90(14):e1231-e1239. PubMed ID: 29514947
[TBL] [Abstract][Full Text] [Related]
6. Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation.
Fialova L; Bartos A; Svarcova J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):286-295. PubMed ID: 28947837
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ
Hampel H; Toschi N; Baldacci F; Zetterberg H; Blennow K; Kilimann I; Teipel SJ; Cavedo E; Melo Dos Santos A; Epelbaum S; Lamari F; Genthon R; Dubois B; Floris R; Garaci F; Lista S;
Alzheimers Dement; 2018 Apr; 14(4):492-501. PubMed ID: 29328927
[TBL] [Abstract][Full Text] [Related]
8. CSF neurofilament light concentration is increased in presymptomatic
Rostgaard N; Roos P; Portelius E; Blennow K; Zetterberg H; Simonsen AH; Nielsen JE
Neurology; 2018 Jan; 90(2):e157-e163. PubMed ID: 29237796
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease.
Lista S; Toschi N; Baldacci F; Zetterberg H; Blennow K; Kilimann I; Teipel SJ; Cavedo E; Dos Santos AM; Epelbaum S; Lamari F; Dubois B; Floris R; Garaci F; Hampel H;
Neurochem Int; 2017 Sep; 108():355-360. PubMed ID: 28527630
[TBL] [Abstract][Full Text] [Related]
10. Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations.
Fabre SF; Forsell C; Viitanen M; Sjögren M; Wallin A; Blennow K; Blomberg M; Andersen C; Wahlund LO; Lannfelt L
Exp Neurol; 2001 Apr; 168(2):413-8. PubMed ID: 11259129
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.
Scherling CS; Hall T; Berisha F; Klepac K; Karydas A; Coppola G; Kramer JH; Rabinovici G; Ahlijanian M; Miller BL; Seeley W; Grinberg LT; Rosen H; Meredith J; Boxer AL
Ann Neurol; 2014 Jan; 75(1):116-26. PubMed ID: 24242746
[TBL] [Abstract][Full Text] [Related]
12. Serum neurofilament light chain as a surrogate of cognitive decline in sporadic and familial frontotemporal dementia.
Silva-Spínola A; Lima M; Leitão MJ; Durães J; Tábuas-Pereira M; Almeida MR; Santana I; Baldeiras I
Eur J Neurol; 2022 Jan; 29(1):36-46. PubMed ID: 34375485
[TBL] [Abstract][Full Text] [Related]
13. Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations.
Rosso SM; van Herpen E; Pijnenburg YA; Schoonenboom NS; Scheltens P; Heutink P; van Swieten JC
Arch Neurol; 2003 Sep; 60(9):1209-13. PubMed ID: 12975285
[TBL] [Abstract][Full Text] [Related]
14. CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging.
Sjögren M; Minthon L; Davidsson P; Granérus A-K ; Clarberg A; Vanderstichele H; Vanmechelen E; Wallin A; Blennow K
J Neural Transm (Vienna); 2000; 107(5):563-79. PubMed ID: 11072752
[TBL] [Abstract][Full Text] [Related]
15. CSF neurofilament proteins in the differential diagnosis of dementia.
de Jong D; Jansen RW; Pijnenburg YA; van Geel WJ; Borm GF; Kremer HP; Verbeek MM
J Neurol Neurosurg Psychiatry; 2007 Sep; 78(9):936-8. PubMed ID: 17314187
[TBL] [Abstract][Full Text] [Related]
16. CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum.
Illán-Gala I; Alcolea D; Montal V; Dols-Icardo O; Muñoz L; de Luna N; Turón-Sans J; Cortés-Vicente E; Sánchez-Saudinós MB; Subirana A; Sala I; Blesa R; Clarimón J; Fortea J; Rojas-García R; Lleó A
Neurology; 2018 Oct; 91(17):e1619-e1628. PubMed ID: 30291183
[TBL] [Abstract][Full Text] [Related]
17. Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications.
Sjögren M; Folkesson S; Blennow K; Tarkowski E
J Neurol Neurosurg Psychiatry; 2004 Aug; 75(8):1107-11. PubMed ID: 15258209
[TBL] [Abstract][Full Text] [Related]
18. Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease.
Alcolea D; Carmona-Iragui M; Suárez-Calvet M; Sánchez-Saudinós MB; Sala I; Antón-Aguirre S; Blesa R; Clarimón J; Fortea J; Lleó A
J Alzheimers Dis; 2014; 42(1):157-67. PubMed ID: 24820015
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.
Grossman M; Farmer J; Leight S; Work M; Moore P; Van Deerlin V; Pratico D; Clark CM; Coslett HB; Chatterjee A; Gee J; Trojanowski JQ; Lee VM
Ann Neurol; 2005 May; 57(5):721-9. PubMed ID: 15852395
[TBL] [Abstract][Full Text] [Related]
20. Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.
Sjögren M; Davidsson P; Wallin A; Granérus AK; Grundström E; Askmark H; Vanmechelen E; Blennow K
Dement Geriatr Cogn Disord; 2002; 13(2):112-8. PubMed ID: 11844893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]